US2019185584A1PendingUtilityA1

Production of heteromultimeric proteins

Assignee: GENENTECH INCPriority: Apr 23, 2010Filed: Jul 25, 2018Published: Jun 20, 2019
Est. expiryApr 23, 2030(~3.7 yrs left)· nominal 20-yr term from priority
A61P 37/02A61P 37/08A61P 35/00C07K 2317/526C07K 2317/92C07K 2317/76C07K 16/247C07K 2317/31C07K 2317/73A61K 2039/505C07K 2317/90C07K 16/244C07K 16/30C12N 15/63C07K 1/107C07K 1/22C07K 16/2863A61P 29/00C07K 16/468A61K 39/395C07K 16/46Y02A50/41Y02A50/30
63
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Described herein are methods for the efficient production of antibodies and other multimeric protein complexes (collectively referred to herein as heteromultimeric proteins) capable of specifically binding to more than one target. The targets may be, for example, different epitopes on a single molecule or located on different molecules. The methods combine efficient, high gene expression level, appropriate assembly, and ease of purification for the heteromultimeric proteins. The invention also provides methods of using these heteromultimeric proteins, and compositions, kits and articles of manufacture comprising these antibodies.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method of preparing a heteromultimeric protein comprising a first hinge-containing polypeptide having a first heterodimerization domain and a second hinge-containing polypeptide having a second heterodimerization domain, wherein the second heterodimerization domain interacts with the first heterodimerization domain, and wherein the first and second hinge-containing polypeptides are linked by at least one interchain disulfide bond, the method comprising the steps of:
 (a) culturing a first host cell comprising a first nucleic acid encoding the first hinge-containing polypeptide under conditions where the hinge-containing polypeptide is expressed;   (b) culturing a second host cell comprising a nucleic acid encoding the second hinge-containing polypeptide under conditions where the hinge-containing polypeptide is expressed;   (c) disrupting the cell membranes of the first and second host cells, wherein the first and second host cells have been combined together in a single suspension; and   (d) recovering the heteromultimeric protein,   
       wherein said method does not require the addition of a reductant. 
     
     
         2 - 89 . (canceled)

Join the waitlist — get patent alerts

Track US2019185584A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.